NCCAM Funding For Botanical/HIV Drug Interaction Research Set At $600,000
This article was originally published in The Tan Sheet
Executive Summary
Grant requests for Phase I/II clinical studies on botanicals' interaction with HIV drugs should "examine the pharmacokinetics or pharmacodynamics of the botanical/drug combination" compared to lone use of either product, the National Center for Complementary & Alternative Medicine says
You may also be interested in...
CAM Bioterrorism, HIV/AIDS Research To Be Funded By NCCAM
Basic and clinical research on the potential benefits of CAM therapies for HIV/AIDS will be sponsored in 2003 by the National Center for Complementary & Alternative Medicine
CAM Bioterrorism, HIV/AIDS Research To Be Funded By NCCAM
Basic and clinical research on the potential benefits of CAM therapies for HIV/AIDS will be sponsored in 2003 by the National Center for Complementary & Alternative Medicine
CAM Bioterrorism, HIV/AIDS Research To Be Funded By NCCAM
Basic and clinical research on the potential benefits of CAM therapies for HIV/AIDS will be sponsored in 2003 by the National Center for Complementary & Alternative Medicine